PRELUDE CAPITAL MANAGEMENT, LLC - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 129 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 2.87 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$24,998
-98.4%
12,562
-96.3%
0.00%
-97.4%
Q4 2020$1,547,000
+45.5%
338,426
+23.5%
0.04%
-23.5%
Q3 2020$1,063,000
+57.5%
273,972
+93.2%
0.05%
+37.8%
Q2 2020$675,000
-10.6%
141,842
-34.6%
0.04%
-27.5%
Q1 2020$755,000
+8288.9%
216,842
+16580.2%
0.05%
Q2 2019$9,000
-59.1%
1,300
-3.1%
0.00%
-100.0%
Q2 2018$22,0001,3410.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$83,503,0007.34%
Eversept Partners, LP 2,656,208$10,306,0872.29%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$62,908,0001.13%
Prosight Management, LP 512,659$1,989,0000.95%
THB ASSET MANAGEMENT 833,104$3,232,0000.90%
GLOBEFLEX CAPITAL L P 251,696$977,0000.26%
XTX MARKETS LLC 10,243$40,0000.19%
HUSSMAN STRATEGIC ADVISORS, INC. 102,000$396,0000.10%
PA Capital LLC 33,874$132,0000.09%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 60,900$236,0000.07%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders